ArticleJournal for immunotherapy of cancer2019

Chemo-immunotherapy improves long-term survival in a preclinical model of MMR-D-related cancer.

Claudia Maletzki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.